Nanomix Corp. (NNMX)

[QuickDraw007]

Boston Therapeutics Presents Findings of BTI-320, a Novel, Non-Systemic, Non-Hypoglycemic Drug Candidate as Therapy to Manage Blood Glucose at 75th Annual Meeting of the American Diabetes Association

http://www.otcmarkets.com/stock/BTHE/news/Boston-Therapeutics-Presents-Findings-of-BTI-320--a-Novel--Non-Systemic--Non-Hypoglycemic-Drug-Candidate-as-Therapy-to-Manage-Blood-Glucose-at-75th-Annual-Meeting-of-the-American-Diabetes-Association?id=106628&b=y